Ivacaftor-treated patients with cystic fibrosis derive long-term benefit despite no short-term clinical improvement

Sonya L. Heltshe, Steven M. Rowe, Michelle Skalland, Arthur Baines, Manu Jain

Research output: Contribution to journalLetterpeer-review

23 Scopus citations
Original languageEnglish (US)
Pages (from-to)1483-1486
Number of pages4
JournalAmerican journal of respiratory and critical care medicine
Volume197
Issue number11
DOIs
StatePublished - Jun 1 2018

Funding

Supported by the Spanish Respiratory Society, Associació Lleidatana de Respiratori, and ResMed. The funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Supported by Cystic Fibrosis Foundation Therapeutics (GOAL11K1, GOAL13K0) and the NIH (DK072482, R35HL135816, DK089507, UL1TR001417, UL1TR002319).

ASJC Scopus subject areas

  • Critical Care and Intensive Care Medicine
  • Pulmonary and Respiratory Medicine

Cite this